Natalia Rahman

Natalia Rahman

Auto-generated profile, based on publicly available information

Natalia Rahman

University College, Oxford, United Kingdom

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2024 in Journal of the American Heart Association
Verified
Journal Article
Open access
AJArun Jose
Arun Jose
NRNatalia Rahman
Natalia Rahman
AOAlexander R. Opotowsky
Alexander R. Opotowsky
TGThomas J. Glorioso
Thomas J. Glorioso
SWStephen W. Waldo
Stephen W. Waldo
BMBradley A. Maron
Bradley A. Maron
Background: Portopulmonary hypertension (PoPH), associated with increased mortality, can limit treatment options for liver diseases. Data on the continuum of clinical risk related to cardiopulmonary hemodynamics in PoPH are lacking. Methods and Results: As part of the United States national Veterans Affairs Clinical Assessment, Reporting, and Tracking database, we performed a retrospective cohort study of adults with cirrhosis undergoing right heart catheterization between October 1, 2017, and September 30, 2022. Pulmonary hypertension (mean pulmonary arterial pressure [mPAP] >20 mm Hg without PoPH) and PoPH (mPAP >20 mm Hg+pulmonary artery wedge pressure ≤15 mm Hg+pulmonary vascular resistance ≥3 WU) were defined by right heart catheterization hemodynamics. Multivariable Cox proportional hazards using natural splines for hemodynamic variables were used to evaluate the association between cardiopulmonary hemodynamics and mortality following right heart catheterization. A total of 4409 patients were included in the final analysis, predominantly men (96.3%), with a mean age of 68.5 years. Pulmonary hypertension and PoPH were observed in 71.6% and 10.2% of the cohort, respectively. Compared with a reference cardiac index of 2.5 L/min per m 2 , the hazard for mortality increased progressively with decreasing cardiac index, even after adjustment for mPAP and pulmonary vascular resistance. The minority of patients with PoPH (N=65, 14.5%) were prescribed pulmonary vasodilator therapy. Conclusions: These data suggest that pulmonary hypertension and PoPH are prevalent in veterans with chronic liver disease, but low use of targeted PoPH therapy persists. Cardiac function discriminated mortality risk across a wide range of mPAP and pulmonary vascular resistance values and may diagnose and clarify prognosis in this patient population.


5 August 2025 in Journal of the American Heart Association
Verified
Journal Article
Open access
VJVijay A. Joshi
Vijay A. Joshi
EBEmily M Bucholz
Emily M Bucholz
MRMarshall Roll
Marshall Roll
NRNatalia Rahman
Natalia Rahman
DKDhaval Kolte
Dhaval Kolte
NBNeel M. Butala
Neel M. Butala
Background: Stroke is a recognized complication following transcatheter aortic valve replacement (TAVR). Although women have historically had a higher rate of bleeding and vascular complications after TAVR, contemporary data on sex differences in post‐TAVR stroke and stroke severity are lacking. Disabling strokes significantly affect quality of life and outcomes, underscoring the need to explore sex‐specific variations in post‐TAVR stroke risk. Methods: In this retrospective cohort study, we included all patients who underwent TAVR in the National Inpatient Sample from 2016 to 2021. Stroke and stroke severity were ascertained using validated claims‐based algorithms. Disabling strokes were defined as those resulting in death or discharge to a nonhome location. We used multivariable logistic regression to evaluate the association between sex and stroke while adjusting for covariates, including cerebral embolic protection use, and accounting for survey weights. Results: Among our weighted sample of 379 410 patients (43.9% female), women demonstrated higher overall in‐hospital stroke incidence compared with men (2.31% versus 1.69%; adjusted odds ratio [aOR], 1.208 [95% CI, 1.082–1.350]). This difference was driven primarily by disabling strokes, which were more common in women (1.61% versus 1.01%; aOR, 1.327 [95% CI, 1.158–1.520]). Conversely, the incidence of nondisabling stroke was not statistically different between sexes (0.70% versus 0.67%;( aOR, 1.013 [95% CI, 0.844–1.215]). Conclusions: Among patients undergoing TAVR in contemporary practice, women had a higher rate of any stroke and disabling strokes compared with men. These findings emphasize the need for tailored strategies to mitigate stroke risk and improve outcomes for female TAVR patients.

21 January 2026 in Heart, Lung and Circulation
Verified
Journal Article
Closed access
NLNeiberg de Alcantara Lima
Neiberg de Alcantara Lima
NRNatalia Rahman
Natalia Rahman
LALuis C. Afonso
Luis C. Afonso
SWStephen W. Waldo
Stephen W. Waldo
CDCreighton W. Don
Creighton W. Don
PRPreeti Ramappa
Preeti Ramappa


1 January 2009 in Heart, Lung and Circulation
Verified
Journal Article
Closed access
PDF file
NRN. Rahman
N. Rahman
RCR.B. Chard
R.B. Chard
STS.P. Thomas
S.P. Thomas